MRK MRK メルク

 MRKのチャート


 MRKの企業情報

symbol MRK
会社名 Merck_Co Inc (MRK メルク)
分野(sector)   
産業(industry)   
業種 医薬品   医療関連(Health Care)
概要 事業概要 メルク(Merck_Co. Inc.)はグローバルな医療会社である。同社は処方薬、ワクチン、生物学的療法、動物医薬品を通じて医療ソリューションの提供に従事する。同社は医薬品、動物健康、医療サービス、及びアライアンスという4つの事業区分により構成される。医薬品事業は同社または合弁会社を通じて直接販売されたヒト健康医薬品とワクチン製品を含む。ヒト健康医薬品はヒトの障害の治療のために処方により販売される治療剤・予防剤を含む。同社はヒト健康医薬品医薬品卸売業者・小売業者、病院、政府機関、保健医療機関・薬局給付管理者等の管理医療機関に販売する。ワクチン製品は予防的小児・青年・成人ワクチンを含み、医師の診療所において提供される。  メルクは米国の医薬品大手。医薬品、ワクチン、動物用医薬品、コンシュ―マ―ケア製品の発見、開発、製造、販売を行う。循環器・糖尿病、がん、骨・呼吸器、皮膚科・眼科、感染症、中枢神経、女性疾患の分野でブランドを展開。ペット用ワクチンや予防薬を提供。抗ヒスタミン剤「クラリトン」や便秘薬「ミララックス」などを扱う。  For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of its mission to save and improve lives. It demonstrates its commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals - including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases - as we aspire to be the premier research-intensive biopharmaceutical company in the world.
本社所在地 908 740-4000
代表者氏名 Kenneth C. Frazier
代表者役職名 Chairman of the Board President Chief Executive Officer
電話番号 +1 908-740-4000
設立年月日 10014
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 69000人
url www.merck.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 16729.00000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 214680.10000
売上高 売上高(百万ドル) 42294.00000
企業価値(EV) 企業価値(EV)(百万ドル) 230930.10000
当期純利益 当期純利益(百万ドル) 6220.00000
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Merck_Co. Inc. revenues increased 5% to $42.29B. Net income before extraordinary items increased 25% to $6.22B. Revenues reflect Merck Pharmaceutical segment increase of 6% to $37.69B United States segment increase of 5% to $18.21B Europe Middle East and Africa segment increase of 6% to $12.21B. Net income benefited from IPR&D impairment charges decrease of 69% to $152M (expense).

 MRKのテクニカル分析


 MRKのニュース

   AIA Group Ltd Buys iShares Core S&P 500 ETF, iShares Core MSCI Europe ETF, S&P 500 ETF ...  2021/08/03 22:38:17 GuruFocus
Related Stocks: IVV , MSFT , CSCO , MRK , V , CL , IEUR , SPY , BBJP , BBAX , SE , TXG , TME , DHR , FTV , FNF , INCY , IBKR ,
   Kitzinger Lautmann Capital Management Inc Buys Cabot Oil & Gas Corp, Cognizant Technology ...  2021/08/03 22:38:03 GuruFocus
Related Stocks: CTSH , WBA , MRK , VZ , KMB , V , COG , REYN , OGN , ESNT , PTEN , DD , BAC , AXP , USB , PEP , CVX , UPS , WMT , GE , RRC , ITW , HTLF ,
   ARGI Investment Services, LLC Buys Amplify BlackSwan Growth & Treasury Core ETF, JPMorgan ...  2021/08/03 20:38:19 GuruFocus
Related Stocks: CHDN , JNJ , MRK , EXC , AEP , K , SWAN , JPME , ISWN , XSD , PALL , IBUY , MET , FIX , ROCK , WGO , NSIT , SMP ,
   Hussman Strategic Advisors, inc Buys Sage Therapeutics Inc, Buckle Inc, JinkoSolar Holding Co, ...  2021/08/03 18:38:23 GuruFocus
Related Stocks: JKS , ETSY , UI , CSIQ , VIAC , DKS , SAGE , BKE , SNBR , EVR , CCS , EAT , CIEN , CHRW , HUM , EA , AKAM , MRK ,
   Questexs Fierce Life Sciences Clinical Quality Oversight Forum is the First Post-Pandemic In-Person Event for the Clinical Research Community  2021/08/03 17:00:00 Intrado Digital Media
The Annual Gathering features Expert Speakers from Astellas, Merck, Roche/Genentech, Avrobio, Clovis Oncology, Boston Scientific, Bill & Melinda Gates MRI and More The Annual Gathering features Expert Speakers from Astellas, Merck, Roche/Genentech, Avrobio, Clovis Oncology, Boston Scientific, Bill & Melinda Gates MRI and More
   June Dogs Of The Dow: Merck Tops By Net Gains  2021/05/30 12:48:10 Seeking Alpha
   Insights on the Rapid Microbiology Testing Global Market to 2027 - Featuring Abbott, Bio-Rad Laboratories and Merck Among Others  2021/05/28 19:42:00 Benzinga
DUBLIN , May 28, 2021 /PRNewswire/ -- The "Rapid Microbiology Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Rapid Microbiology Testing estimated at US$3.9 Billion in the year 2020, is projected to reach a revised size of US$6.2 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Kits segment is readjusted to a revised 7.4% CAGR for the next 7-year period. The U.S. Market is Estimated at $1.1 Billion , While China is Forecast to Grow at 10.4% CAGR The Rapid Microbiology Testing market in the U.S. is estimated at US$1.1 Billion in the year 2020. China , the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing …
   Biliary Tract Cancer Treatment Outlook: A Review on Upcoming Therapies  2021/05/28 00:00:00 Benzinga
Los Angeles, USA, May 27, 2021 (GLOBE NEWSWIRE) -- Biliary Tract Cancer Treatment Outlook: A Review on Upcoming Therapies Although Biliary Tract Cancers are rare with a poor prognosis, the increasing prevalence has increased the demand for combination therapy owing to the better treatment options. The extensive Research and Development by Pharmaceutical companies may primarily contribute to the availability of affordable treatment for Biliary Tract Cancer patients. DelveInsight's " Biliary Tract Cancer (BTC) Pipeline Insight " report provides comprehensive insights about 50 + companies and 50 + pipeline drugs in the BTC pipeline landscapes. It comprises Biliary Tract Cancer pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Biliary Tract Cancer therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Biliary Tract Cancer pipeline products. Some of the key takeaways of the Biliary Tract Cancer Pipeline Report Prominent companies such as Lee's Pharmaceutical, Jiangsu HengRui Medicine, Miracogen, RemeGen, J-Pharma, Hutchison Medipharma, Merck KGaA, AstraZeneca, and others are developing potential drug candidates to boost the Biliary Tract Cancer treatment scenario.
   Cathie Wood Loads Up $27.4M In Okta On Dip, Also Adds Zoom  2021/05/27 23:21:00 Benzinga
Cathie Wood-led Ark Investment Management bought 123,385 shares, estimated to be worth about $27.44 million, in Okta Inc (NASDAQ: OKTA) on Thursday. Okta …
   Oscar Isaac will star in Disney Plus’ Moon Knight series  2021/05/27 23:01:07 The Verge
Photo by Karwai Tang/WireImage Marvel has confirmed that Oscar Isaac will star in the Disney Plus Moon Knight series, bringing the Star Wars star to another highly lucrative side of the Disney empire. Moon Knight is one of several Marvel characters who seem to be inspired by DC Comics’ Batman, and is certainly more of an obscure character to adapt, but as the company pivots into the next phase of movies and now shows , weirdness is on the menu. Moon Knight , or Marc Spector, is a mercenary possessed by an ancient Egyptian moon god named Khonshu. That possession is what gives him his superpowers but also multiple conflicting personalities, including a taxi driver, wealthy playboy, and masked vigilante. Marvel and Isaac’s announcement — “WE ARE MOONKNIGHT” — seems to… Continue reading…
   Molsheim: Merck baut Kapazitäten mit Millionen-Investitionen in Frankreich aus  2021/03/17 15:46:16 Handelsblatt
An einem Standort in Frankreich plant Merck eine neue Produktionseinheit für Single-Use-Verbrauchsmaterialien. 350 Arbeitsplätze sollen entstehen.
   New Report Explores Hottest Trends in Human Rotavirus Vaccine Market 2021-2025: International Key Vendors – GSK, Bharat Biotech, Merck  2021/03/17 14:27:41 OpenPR
Global Human Rotavirus Vaccine Market Synopsis: The report covers a forecast and an analysis of the Human Rotavirus Vaccine Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast
   How COVID-19 Impacting Live Vaccines Market? Top Key Players : Astellas Pharma Inc., Pfizer Inc., Merck KGaA, AstraZeneca plc, Bharat Biotech, Sun Pharmaceutical Industries Limited  2021/03/17 13:30:37 OpenPR
The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock
   Amathus Therapeutics Signs Strategic Collaboration With Merck to Develop Treatments for Neurodegenerative Diseases  2021/03/17 12:00:00 Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amathus Therapeutics signs strategic collaboration with Merck to Develop Treatments for Neurodegenerative Diseases.
   The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes  2021/03/17 11:43:07 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 16) Affimed N.V. (NASDAQ: AFMD ) BioAtla, Inc. (NASDAQ: BCAB ) Champions Oncology, Inc. (NASDAQ: CSBR ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Myriad Genetics, Inc. (NASDAQ: MYGN ) Omnicell, Inc. (NASDAQ: OMCL ) Savara Inc. (NASDAQ: SVRA ) (reacted to a positive analyst action and insider buying) Sierra Oncology, Inc. (NASDAQ: SRRA ) Sol-Gel Technologies Ltd. (NASDAQ: SLGL ) Vincerx Pharma, Inc. (NASDAQ: VINC ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 16) Galecto, Inc. (NASDAQ: GLTO ) Immunocore Holdings plc (NASDAQ: IMCR ) Stocks In Focus Pfizer to Sell Chinese Biologics Unit to WuXi Pfizer Inc.'s (NYSE: PFE ) China unit and Hong Kong-listed WuXi Biologics announced an equity agreement under which the latter will acquire the former's state-of-the-art biologics manufacturing facilities as well as its labor force in Hangzhou, China.

 関連キーワード  (医薬品 米国株 MRK メルク MRK )

 twitter  (公式ツイッターやCEOツイッターなど)

MRK動画